228.92MMarket Cap-1603P/E (TTM)
9.0698High8.4600Low213.60KVolume8.5900Open8.5900Pre Close1.88MTurnover0.84%Turnover RatioLossP/E (Static)25.91MShares14.748052wk High2.42P/B225.25MFloat Cap3.888052wk Low--Dividend TTM25.50MShs Float2352.0000Historical High--Div YieldTTM7.10%Amplitude3.8880Historical Low8.8070Avg Price1Lot Size
Inovio Pharmaceuticals Stock Forum
Inovio Receives Advanced Therapy Medicinal Product Certificate From European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate Ino-3107
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...
No comment yet